Insider · CIK 0001187572
John B Henneman III
director
Files at OFIX (Orthofix Medical Inc.), ANIK (Anika Therapeutics, Inc.), APRE (Aprea Therapeutics, Inc.), RCM (R1 RCM Inc. /DE). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | ANIK Anika Therapeutics, Inc. | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 49,871 | Jun 24, 2025 |
| Jun 18, 2025 | OFIX Orthofix Medical Inc. | AGrant or award Common Stock | +18,841 | $0.00 | $0 | 83,706 | Jun 23, 2025 |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Common Stock | +1,045 | $0.00 | $0 | 10,229 | Jun 9, 2025 |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +4,185 | $0.00 | $0 | 4,185 | Jun 9, 2025 |
| Nov 19, 2024 | RCM R1 RCM Inc. /DE | DDisposition to issuer Common Stock | -87,765 | $14.30 | $1.3M | 0 | Nov 19, 2024 |
| Nov 19, 2024 | RCM R1 RCM Inc. /DE | DDisposition to issuer Director Stock Option (right to buy)derivative | -515,715 | - | - | 0 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.